Biol stock forecast.

Find the latest Precision BioSciences, Inc. (DTIL) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...BIOLASE Stock Forecast 20 Oct. Presumably, on 10/20/2023, the price of shares will be in the range of $1.76 - $1.88. A $0.11 range width can provide 6.53% volatility. The weighted average price of this range is at $1.82, which is $0.02 higher than the previous day's weighted average price.In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.Find the latest Amgen Inc. (AMGN) stock quote, history, news and other vital information to help you with your stock trading and investing.

The 3 analysts offering 1 year price forecasts for BIOL have a max estimate of — and a min estimate of —. Analyst rating Based on 3 analysts giving stock ratings to BIOL in the past 3 months.Hence, Semenkow has refined her 3L+ MM forecasts to reflect a more gradual launch in 2024. Even though these changes have resulted in a lower target price to $9 per share (a reduction of $2), she ...

Oct 26, 2023 · With the interplay of data, predictions, and real-time performance, BIOLASE's stock emerges not just as an investment opportunity but as a narrative unfolding in the grand theatre of the financial markets. Each high, low, surge, and dip is a chapter, and every investor, a reader and co-author of this evolving tale. Find the latest Leap Therapeutics, Inc. (LPTX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...

How much is Biolase stock worth today? ( NASDAQ: BIOL) Biolase currently has 2,296,777 outstanding shares. With Biolase stock trading at $1.25 per share, the total value of Biolase stock (market capitalization) is $2.87M. Biolase stock was originally listed at a price of $38,049.71 in Dec 31, 1997. Jul 25, 2023 · Wood, a seasoned biotech investor, has gotten in front of this emerging trend by buying shares in several leading genomics companies. Among her various holdings in this high-growth area, Prime ... Based on short-term price targets offered by three analysts, the average price target for Biolase comes to $15.67. The forecasts range from a low of $3.00 to a …Dec 1, 2023 · The firm earned $10.92 million during the quarter. BIOLASE has generated ($158.82) earnings per share over the last year ( ($158.82) diluted earnings per share). BIOLASE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off prior year's report dates.

MarketWatch IBD Sign In Biolase Inc. BIOL (U.S.: Nasdaq) Overview News Biolase Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-158.42...

7. Synlogic (SYBX) Synlogic (SYBX) is a company at the interface of biology and engineering, pioneering the use of synthetic biology to create new types of living therapies. Currently, the stock is worth roughly $2.00. According to LinkedIn, they have over 80 employees, and they are based in Cambridge, Massachusetts.

Brickell Biotech, Inc. (NASDAQ:BBI) released its quarterly earnings data on Thursday, August, 11th. The company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($1.48) by $1.47. Brickell Biotech had a negative trailing twelve-month return on equity of 156.10% and a negative net margin of 643.48%.Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic ...Stock Price Forecast The 29 analysts offering 12-month price forecasts for NIO Inc have a median target of 12.41, with a high estimate of 22.22 and a low estimate of 4.60.In that case, then, we find that the current price level is -1664.71% off the targeted high while a plunge would see the stock gain -1664.71% from current levels. Intelligent Bio Solutions Inc (INBS) estimates and forecasts. Figures show that Intelligent Bio Solutions Inc shares have outperformed across the wider relevant industry.For X4 Pharmaceuticals stock forecast for 2024, 12 predictions are offered for each month of 2024 with average X4 Pharmaceuticals stock forecast of $0.6, a high forecast of $0.75, and a low forecast of $0.5. The average X4 Pharmaceuticals stock forecast 2024 represents a -25.05% decrease from the last price of $0.800599992275238.

It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...The BOIL ETF price gained 0.81% on the last trading day (Thursday, 30th Nov 2023), rising from $36.00 to $36.29. During the last trading day the ETF fluctuated 6.05% from a day low at $35.20 to a day high of $37.33. The price has fallen in 8 of the last 10 days and is down by -29.62% for this period. Volume fell on the last day by -27 …1 equities research analysts have issued 1 year price targets for Cassava Sciences' shares. Their SAVA share price targets range from $11.00 to $124.00. On average, they predict the company's share price to reach $54.33 in the next year. This suggests a possible upside of 154.5% from the stock's current price.Oct 26, 2023 · With the interplay of data, predictions, and real-time performance, BIOLASE's stock emerges not just as an investment opportunity but as a narrative unfolding in the grand theatre of the financial markets. Each high, low, surge, and dip is a chapter, and every investor, a reader and co-author of this evolving tale. With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.Find the latest First Wave BioPharma, Inc. (FWBI) stock quote, history, news and other vital information to help you with your stock trading and investing.1.62K. 100.03%. Get the latest BIOLASE Inc (BIOL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic ...A high-level overview of BIOLASE, Inc. (BIOL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Dec 1, 2023 · The firm earned $10.92 million during the quarter. BIOLASE has generated ($158.82) earnings per share over the last year ( ($158.82) diluted earnings per share). BIOLASE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off prior year's report dates. Forecast for July 2025. It is predicted that the price of one BIOLASE share in will be in the range of $0.95 to $1.11. The width of this range will be $0.17 (15.15%). The average price is $1.05, which is $0.07 higher than the average price of the previous month.Find real-time PTON - Peloton Interactive Inc stock quotes, company profile, news and forecasts from CNN Business.Find real-time AITX - Artificial Intelligence Technology Solutions Inc stock quotes, company profile, news and forecasts from CNN Business.23 de nov. de 2023 ... Biolase Inc (NASDAQ:BIOL) price on Wednesday, November 22, fall -1.61% below its previous day's close as a downside momentum from buyers ...The current average BIOL price target, as estimated by these analysts, is $0.00. The predictions for the future BIOL stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for BIOL. BIOL N/A N/A Short Interest (10/31/23) Shares Sold Short 8,569 Change from Last -70.26% Percent of Float 0.43% Stock Money Flow N/A Research & Ratings Biolase Inc. Per …

For X4 Pharmaceuticals stock forecast for 2024, 12 predictions are offered for each month of 2024 with average X4 Pharmaceuticals stock forecast of $0.6, a high forecast of $0.75, and a low forecast of $0.5. The average X4 Pharmaceuticals stock forecast 2024 represents a -25.05% decrease from the last price of $0.800599992275238.

Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...

Find the latest bluebird bio, Inc. (BLUE) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...With the interplay of data, predictions, and real-time performance, BIOLASE's stock emerges not just as an investment opportunity but as a narrative unfolding in the grand theatre of the financial markets. Each high, low, surge, and dip is a chapter, and every investor, a reader and co-author of this evolving tale.Target values for the price of one BIOLASE share for Aug 2024. The weighted average target price per BIOLASE share in Aug 2024 is: 1.67. In Aug, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 14.327% volatility is expected. Pessimistic target level: 1.51. Optimistic target level: 1.77.Find the latest BioLargo, Inc. (BLGO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Nov 14, 2023 · BIOLASE stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for BIOLASE analysts is $ 22.25 . Today 200 Day Moving Average is the resistance level ( 17.28 $). DRRX Stock 12 Months Forecast. $8.50. (1187.88% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Durect in the last 3 months. The average price target is $8.50 with a high forecast of $8.50 and a low forecast of $8.50. The average price target represents a 1187.88% change from the last price of $0.66. The value each BIOL share was expected to gain vs. the value that each BIOL share actually gained. BIOLASE ( BIOL) reported Q2 2023 earnings per share (EPS) of -$8.93, missing estimates of -$5.33 by 67.48%. In the same quarter last year, BIOLASE 's earnings per share (EPS) was -$90.62. BIOLASE is expected to release next earnings on -, with an ... Dec 1, 2023 · It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ... BIOL Stock. USD 0.08 0.0001 0.13%. BIOLASE stock price prediction is an act of determining the future value of BIOLASE shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of BIOLASE's future price could yield a significant profit.Hence, Semenkow has refined her 3L+ MM forecasts to reflect a more gradual launch in 2024. Even though these changes have resulted in a lower target price to $9 per share (a reduction of $2), she ...Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...Discover historical prices for BIOL stock on Yahoo Finance. View daily, weekly or monthly format back to when BIOLASE, Inc. stock was issued.

Nov 10, 2023 · Check out our BIOL stock analysis, current BIOL quote, charts, and historical prices for Biolase Inc stock. ... BIOL Stock Predictions, Articles, and Biolase Inc News Dec 1, 2023 · Full Company Report for BIOL. View Biolase, Inc BIOL investment & stock information. Get the latest Biolase, Inc BIOL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. See the latest Biolase Inc stock price (BIOL:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Price Prediction BIOLASE price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.Instagram:https://instagram. scan stockshealthcare home loan programam theatrescplf A high-level overview of BIOLASE, Inc. (BIOL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Find the latest Bio-Rad Laboratories, Inc. (BIO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ... nyse siteplatinum etfs TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com kkr nyse Jul 26, 2023 · COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON JULY 28, 2023. LAKE FOREST, Calif., July 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the Company's stockholders granted the Board of Directors the discretion to effect a ... The 12-month stock price forecast is $113.33, which is an increase of 9,594.61% from the latest price. Price Target ( 9,594.61% upside) Analyst Consensus: Strong Buy News All Videos Press Releases Conversation